Antimicrobial Agents Practice Questions

Q: All of the following are true about levamisole except:

A single dose is sufficient for the treatment of psoriasis.. **Explanation:** Levamisole is a synthetic imidazothiazole derivative primarily used as an anthelmintic and an immunomodulator. **Why Option C is the correct answer (False statement):** Levamisole is **not** a first-line treatment for psoriasis, and a single dose is never sufficient. While it has been explored in various autoimmune conditions due to its immunomodulatory effects, its use in psoriasis is rare, experimental, and requires prolonged, intermittent dosing (e.g., 150 mg daily for 2-3 days every week). It is more commonly associated with the treatment of nephrotic syndrome in children and formerly as an adjuvant in colorectal cancer. **Analysis of Incorrect Options (True statements):** * **Option A & B:** Levamisole acts as an **immunomodulator**. At low or standard doses, it restores T-cell and macrophage function (immunostimulator). However, at high doses or prolonged use, it can lead to immunosuppression and serious adverse effects like agranulocytosis. * **Option D:** As an anthelmintic, it acts as a **nicotinic acetylcholine receptor agonist**. It causes persistent depolarization and spastic paralysis in susceptible worms (like *Ascaris lumbricoides*), leading to their expulsion. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice:** Levamisole was historically a drug of choice for Ascariasis (single dose), though Albendazole is now preferred. 2. **Adverse Effect:** The most dreaded side effect is **agranulocytosis**. 3. **Clinical Trivia:** It is often used as an adulterant in "street cocaine," which can lead to **retiform purpura** and skin necrosis. 4. **Mechanism:** It "restores" rather than "stimulates" the immune system (restores depressed T-cell function).

Q: Treatment with what antibiotic is most likely to have resulted in this patient's skin changes?

Minocycline. ***Minocycline*** - **Minocycline** is well-known for causing distinctive **blue-grey to blue-black skin hyperpigmentation**, particularly in sun-exposed areas and mucous membranes. - This **irreversible pigmentation** occurs due to deposition of **minocycline-melanin complexes** in tissues, making it a classic adverse effect of long-term tetracycline therapy. *Rifampin* - **Rifampin** typically causes **orange-red discoloration** of body fluids (urine, tears, saliva) but not the blue-grey skin changes described. - Known adverse effects include **hepatotoxicity** and **flu-like syndrome**, not characteristic skin pigmentation. *Chloramphenicol* - **Chloramphenicol** is associated with serious **bone marrow suppression** (aplastic anemia) and **grey baby syndrome** in neonates. - Does not cause the distinctive **blue-grey skin hyperpigmentation** characteristic of minocycline therapy. *Nitrofurantoin* - **Nitrofurantoin** commonly causes **pulmonary toxicity** (acute pneumonitis, chronic fibrosis) and **peripheral neuropathy**. - Skin pigmentation changes are not a recognized adverse effect of **nitrofurantoin** therapy.

Q: Which anti-tubercular drug is generally not given in patients with liver disease?

Pyrazinamide. **Explanation:** The management of tuberculosis in patients with pre-existing liver disease requires careful selection of drugs, as three out of the four first-line agents are hepatotoxic. **Why Pyrazinamide is the correct answer:** Pyrazinamide (PZA) is considered the **most hepatotoxic** of all first-line anti-tubercular drugs (ATDs). It causes dose-dependent hepatotoxicity and can lead to prolonged liver injury. According to standard guidelines (WHO/RNTCP), if a patient has unstable or advanced chronic liver disease, Pyrazinamide is the first drug to be excluded from the regimen to prevent fulminant hepatic failure. **Analysis of Incorrect Options:** * **Isoniazid (INH):** While INH is hepatotoxic (causing idiosyncratic hepatitis), it is often retained in modified regimens for liver disease unless the liver injury is severe, as its therapeutic benefit is high. * **Rifampicin:** It is also hepatotoxic and can cause transient cholestatic jaundice. However, it is less hepatotoxic than Pyrazinamide and is usually the backbone of "liver-safe" regimens (e.g., 2HRE + 7HR). * **Ethambutol:** This is the correct choice for patients with liver disease because it is **not hepatotoxic**. It is primarily excreted by the kidneys. **NEET-PG High-Yield Pearls:** 1. **Hepatotoxicity Order:** Pyrazinamide > Isoniazid > Rifampicin. 2. **Safe Drugs in Liver Disease:** Ethambutol and Streptomycin (neither is metabolized by the liver). 3. **Regimen for Stable Chronic Liver Disease:** If the liver is compensated, a regimen like **2HRE + 7HR** (avoiding Pyrazinamide) is commonly used. 4. **Monitoring:** If ALT/AST levels rise >3 times the upper limit of normal with symptoms, or >5 times without symptoms, all hepatotoxic drugs must be stopped immediately.

Q: All of the following antibodies require dose adjustment in renal failure except?

Erythromycin. **Explanation:** The primary factor determining whether a drug requires dose adjustment in renal failure is its **route of elimination**. [1] Drugs that are primarily excreted unchanged by the kidneys or have active metabolites cleared renally require dose modification to prevent toxicity. [1] **Why Erythromycin is the Correct Answer:** Erythromycin is a macrolide antibiotic that is primarily metabolized by the liver and excreted via the **bile and feces**. Only a small fraction (approx. 2–5%) is excreted unchanged in the urine. Therefore, its clearance is not significantly affected by declining renal function, making it safe to use without dose adjustment in renal failure. **Analysis of Incorrect Options:** * **Gentamicin:** This aminoglycoside is eliminated almost entirely by glomerular filtration. It is highly nephrotoxic; dose adjustment (based on creatinine clearance) is mandatory to prevent further renal damage and ototoxicity. [2] * **Ceftriaxone:** Although it has dual elimination (biliary and renal), it still requires monitoring and potential adjustment in patients with combined renal and hepatic impairment. [2] In isolated severe renal failure, while often considered safer than other cephalosporins, most guidelines still suggest caution or minor adjustments at maximum doses. * **Isoniazid:** While primarily metabolized by the liver (acetylation), its metabolites are excreted renally. In end-stage renal disease (ESRD), dose reduction is often recommended to prevent neurotoxicity. **NEET-PG High-Yield Pearls:** * **Mnemonic for drugs NOT requiring dose adjustment in renal failure:** "**D**o **C**areful **L**iver **M**etabolism" (**D**oxycycline, **C**eftriaxone/Cefoperazone, **L**inezolid, **M**acrolides/Metronidazole). * **Doxycycline** is the tetracycline of choice in renal failure because it is excreted via the gut. [2] * **Aminoglycosides and Vancomycin** always require Therapeutic Drug Monitoring (TDM) in renal impairment.

Q: Which of the following drugs does NOT cause a curare-like effect?

Chloramphenicol. ### Explanation The "curare-like effect" refers to the **neuromuscular blockade (NMB)** caused by certain antibiotics, which can lead to muscle weakness or respiratory paralysis, especially when used alongside skeletal muscle relaxants or in patients with Myasthenia Gravis. **1. Why Chloramphenicol is the correct answer:** Chloramphenicol acts by inhibiting the 50S ribosomal subunit to prevent protein synthesis. Unlike several other classes of antibiotics, it has **no documented interference** with the release of acetylcholine or the sensitivity of the post-junctional membrane at the neuromuscular junction. Therefore, it does not cause neuromuscular blockade. **2. Why the other options are incorrect:** * **Streptomycin (Aminoglycosides):** This is the most common class associated with this effect. Aminoglycosides inhibit the pre-junctional release of Acetylcholine (ACh) and reduce post-junctional sensitivity to ACh. Neomycin and Streptomycin carry the highest risk. * **Polymyxin (B and Colistin):** These drugs exert a detergent-like action on the post-junctional membrane, causing non-depolarizing blockade that is often **not** reversible by neostigmine. * **Tetracycline:** While less common than aminoglycosides, tetracyclines can aggravate muscle weakness by chelating calcium ions, which are essential for ACh release at the motor endplate. ### NEET-PG High-Yield Pearls: * **Management:** Aminoglycoside-induced blockade is best reversed by **Intravenous Calcium Gluconate** (which promotes ACh release), while neostigmine is less consistently effective. * **Contraindication:** Avoid these "curare-like" antibiotics in patients with **Myasthenia Gravis**. * **Order of Potency for NMB:** Neomycin > Streptomycin > Amikacin > Gentamicin. * **Lincosamides (Clindamycin):** Also cause significant neuromuscular blockade by acting both pre- and post-junctionally.

Q: The mechanism of action of chloramphenicol is inhibition of synthesis of:

Protein. **Explanation:** **Mechanism of Action (Correct Answer: C)** Chloramphenicol is a broad-spectrum bacteriostatic antibiotic. It inhibits **protein synthesis** by reversibly binding to the **50S ribosomal subunit**. Specifically, it inhibits the enzyme **peptidyl transferase**, which prevents the attachment of new amino acids to the growing peptide chain (transpeptidation). **Analysis of Incorrect Options:** * **A. Cell Wall:** Inhibition of cell wall synthesis is the mechanism of Beta-lactams (Penicillins, Cephalosporins), Vancomycin, and Bacitracin. * **B. Cell Membrane:** Agents like Polymyxins (Polymyxin B, Colistin) and Daptomycin act by disrupting the integrity of the bacterial cell membrane. * **D. DNA:** Inhibition of DNA synthesis or function is characteristic of Fluoroquinolones (DNA gyrase/Topoisomerase IV) and Metronidazole (DNA strand breakage). **High-Yield Clinical Pearls for NEET-PG:** * **Gray Baby Syndrome:** Occurs in neonates due to a deficiency of the hepatic enzyme **glucuronyl transferase**, leading to drug accumulation, cyanosis, and circulatory collapse. * **Bone Marrow Toxicity:** Can cause dose-dependent anemia or the more dreaded, idiosyncratic **Aplastic Anemia** (irreversible). * **Resistance:** Primarily mediated by the production of **Chloramphenicol acetyltransferase**, which inactivates the drug. * **Drug of Choice:** Historically used for Typhoid and Meningitis, but now largely restricted to topical use or life-threatening infections where safer alternatives are unavailable.

Question 1

All of the following are true about levamisole except:

Accepted Answer

A single dose is sufficient for the treatment of psoriasis.

Answer

Acts as an immunostimulator.

Answer

Acts as an immunodepressor in high doses.

Answer

Acts as an antihelminthic by causing depolarization.

Question 2

All of the following statements about penicillin-binding proteins are true EXCEPT:

Accepted Answer

Methicillin-resistant Staphylococcus aureus (MRSA) has acquired a PBP with very high affinity for beta-lactam antibiotics.

Answer

Present on the cell surface

Answer

Mutation in PBPs gives rise to resistance

Answer

They are target sites of vancomycin

Question 3

Treatment with what antibiotic is most likely to have resulted in this patient's skin changes?

Accepted Answer

Minocycline

Answer

Rifampin

Answer

Chloramphenicol

Answer

Nitrofurantoin

Question 4

Which anti-tubercular drug is generally not given in patients with liver disease?

Accepted Answer

Pyrazinamide

Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Question 5

All of the following antibodies require dose adjustment in renal failure except?

Accepted Answer

Erythromycin

Answer

Ceftriaxone

Answer

Isoniazid

Answer

Gentamicin

Question 6

Tetracyclines are the first drug of choice for which of the following conditions EXCEPT?

Accepted Answer

Community-acquired pneumonia

Answer

Granuloma inguinale

Answer

Cholera

Answer

Atypical pneumonia

Question 7

What is the recommended dose of Artemether for severe malaria?

Accepted Answer

2.4 mg/kg

Answer

1.2 mg/Kg

Answer

1.7 mg/kg

Answer

3.4 mg/kg

Question 8

Which of the following antifungal drugs has only topical action?

Accepted Answer

Clotrimazole

Answer

Fluconazole

Answer

Ketoconazole

Answer

Itraconazole

Question 9

Which of the following drugs does NOT cause a curare-like effect?

Accepted Answer

Chloramphenicol

Answer

Polymyxin

Answer

Tetracycline

Answer

Streptomycin

Question 10

The mechanism of action of chloramphenicol is inhibition of synthesis of:

Accepted Answer

Protein

Answer

Cell wall

Answer

Cell membrane

Answer

DNA

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?